| Financial crisis and austerity measures in Greece: their impact on health promotion policies and public health care AA Ifanti, AA Argyriou, FH Kalofonou, HP Kalofonos Health policy 113 (1-2), 8-12, 2013 | 301 | 2013 |
| Physicians’ brain drain in Greece: a perspective on the reasons why and how to address it AA Ifanti, AA Argyriou, FH Kalofonou, HP Kalofonos Health Policy 117 (2), 210-215, 2014 | 112 | 2014 |
| Clinical outcomes and toxic effects of single-agent immune checkpoint inhibitors among patients aged 80 years or older with cancer: a multicenter international cohort study CA Nebhan, A Cortellini, W Ma, T Ganta, H Song, F Ye, R Irlmeier, ... JAMA oncology 7 (12), 1856-1861, 2021 | 92 | 2021 |
| Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: experience beyond the clinical trials J Bruna, AA Argyriou, GG Anastopoulou, M Alemany, E Nadal, ... Journal of the Peripheral Nervous System 25 (2), 171-177, 2020 | 43 | 2020 |
| Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel‐induced peripheral neurotoxicity in breast cancer patients S Karteri, J Bruna, AA Argyriou, S Mariotto, R Velasco, M Alemany, ... Journal of the Peripheral Nervous System 27 (2), 166-174, 2022 | 29 | 2022 |
| Immune-driven pathogenesis of neurotoxicity after exposure of cancer patients to immune checkpoint inhibitors N Vilariño, J Bruna, F Kalofonou, GG Anastopoulou, AA Argyriou International journal of molecular sciences 21 (16), 5774, 2020 | 27 | 2020 |
| Rheumatic manifestations in patients treated with immune checkpoint inhibitors K Melissaropoulos, K Klavdianou, A Filippopoulou, F Kalofonou, ... International journal of molecular sciences 21 (9), 3389, 2020 | 26 | 2020 |
| Expression of intracellular components of the NF-κB alternative pathway (NF-κB2, RelB, NIK and Bcl3) is associated with clinical outcome of NSCLC patients FID Dimitrakopoulos, AG Antonacopoulou, AE Kottorou, N Panagopoulos, ... Scientific reports 9 (1), 14299, 2019 | 25 | 2019 |
| Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study AA Argyriou, S Karteri, J Bruna, S Mariotto, M Simo, D Velissaris, ... Supportive Care in Cancer, 1-8, 2022 | 19 | 2022 |
| PIOS (patras immunotherapy score) score is associated with best overall response, progression-free survival, and post-immunotherapy overall survival in patients with advanced … FI Dimitrakopoulos, A Nikolakopoulos, A Kottorou, F Kalofonou, E Liolis, ... Cancers 12 (5), 1257, 2020 | 11 | 2020 |
| Real world, open label experience with lacosamide against acute painful oxaliplatin‐induced peripheral neurotoxicity AA Argyriou, F Kalofonou, P Litsardopoulos, GG Anastopoulou, ... Journal of the Peripheral Nervous System 25 (2), 178-183, 2020 | 8 | 2020 |
| Sensitive screening of single nucleotide polymorphisms in cell free DNA for diagnosis of gestational tumours GJ Maher, RA Fisher, B Kaur, X Aguiar, P Aravind, N Cedeno, J Clark, ... NPJ Genomic Medicine 7 (1), 26, 2022 | 7 | 2022 |
| Oxaliplatin rechallenge in metastatic colorectal cancer patients with clinically significant oxaliplatin‐induced peripheral neurotoxicity AA Argyriou, F Kalofonou, P Litsardopoulos, GG Anastopoulou, ... Journal of the Peripheral Nervous System 26 (1), 43-48, 2021 | 5 | 2021 |
| Anti-PD-1 associated retroperitoneal fibrosis D Daoussis, P Kraniotis, F Kalofonou, H Kalofonos Rheumatology 60 (9), e329-e330, 2021 | 4 | 2021 |
| MiR-27a-3p: An AR-modulatory microRNA with a distinct role in prostate cancer progression and therapy. F Kalofonou, A Sita-Lumsden, D Leach, C Fletcher, J Waxman, CL Bevan Journal of Clinical Oncology 38 (6_suppl), 193-193, 2020 | 4 | 2020 |
| Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers A Samani, R Bennett, K Eremeishvili, F Kalofonou, S Whear, A Montes, ... ESMO open 7 (2), 100401, 2022 | 2 | 2022 |
| NF-κB2 and RELB offer prognostic information in colorectal cancer and NFKB2 rs7897947 represents a genetic risk factor for disease development A Antonacopoulou, AE Kottorou, FI Dimitrakopoulos, S Marousi, ... Translational Oncology 14 (1), 100912, 2021 | 2 | 2021 |
| Small Extracellular Vesicles (sEVs) Biogenesis Molecular Players Are Associated with Clinical Outcome of Colorectal Cancer Patients A Kottorou, FI Dimitrakopoulos, G Diamantopoulou, F Kalofonou, ... Cancers 15 (6), 1685, 2023 | 1 | 2023 |
| Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European … FI Dimitrakopoulos, G Mountzios, P Christopoulos, T Papastergiou, ... Therapeutic Advances in Medical Oncology 14, 17588359221122728, 2022 | 1 | 2022 |
| PIOS ratio: predicting the best response of non-small-cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors. FID Dimitrakopoulos, A Nikolakopoulos, AE Kottorou, E Liolis, T Frantzi, ... Journal of Clinical Oncology 38 (15_suppl), e21507-e21507, 2020 | 1 | 2020 |
